Hospital Universitario Vall d'Hebron (VHIR)

Barcelona 08035

0 studies enrolling now · 1 studies all time

What they study most

Adenocarcinoma of Lung, Lung Cancer Metastatic, NSCLC Stage IV

Studies at this site

• Bemcentinib (BGB324) in Combination With Pembrolizumab in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) — Completed